Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide funding-status notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-03T23:59:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    UI changes to the history view include a glossary toggle, green highlights for additions, red highlights for deletions, and visible revision/version labeling. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T00:14:10.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new site revision (v3.3.4) was added, replacing the previous revision (v3.3.3). This change affects page metadata and does not modify trial data, status, or details.
    Difference
    0.1%
    Check dated 2026-01-14T01:52:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The changes consist of adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:33:45.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; the update appears to be a platform/UI change with no changes to the study records or history data.
    Difference
    0.1%
    Check dated 2025-11-24T16:58:42.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the page.
    Difference
    0.5%
    Check dated 2025-11-17T15:03:41.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.